
Klaria Pharma Holding Investor Relations Material
Latest events

Q2 2025
28 Aug, 2025

Q1 2025
21 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Klaria Pharma Holding
Access all reports
Klaria Pharma Holding AB is a Swedish biotechnology and medical research company focused on developing and commercializing therapeutic drugs. The company's core technology involves a patented drug delivery platform using an alginate-based polymer film that facilitates rapid and reliable transmucosal absorption. This innovative method allows the medication to be distributed directly into the bloodstream via a mucoadhesive film, offering benefits such as shorter time to effect, increased control, and simple handling. The company is headquartered in Uppsala, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
The Dilemma That Brought Down Kodak
Kodak helped invent digital photography but failed to embrace it. How the innovator's dilemma turned an icon into its own most famous casualty.
21 Aug 2025
)
Maziar Mike Doustdar: Novo Nordisk's New CEO
A portrait of the pharmaceutical giant's new CEO, who assumes the position at a critical time for the company in its competition with Eli Lilly.
12 Aug 2025
)
Novo Nordisk: Tipping the Scale of Innovation
Taking a look at the company behind Ozempic and Wegovy and diving into their history, business, and the challenges it now faces
8 Aug 2025
Ticker symbol
KLAR
Country
🇸🇪 Sweden